共 160 条
- [1] Llovet JM(2012)EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma J Hepatol 56 908-943
- [2] Bruix J(2008)Novel advancements in the management of hepatocellular carcinoma in 2008 J Hepatol 48 S20-37
- [3] Wong J(2016)Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan liver cancer association and the gastroenterological society of Taiwan J Formos Med Assoc 2018 381-403
- [4] Lee KF(2013)Percutaneous radiofrequency ablation versus surgical radiofrequency ablation for malignant liver tumours: the long-term results HPB (Oxford) 15 595-601
- [5] Yu CH(2013)Ten-year outcomes of percutaneous radiofrequency ablation as first-line therapy of early hepatocellular carcinoma: analysis of prognostic factors J Hepatol 58 89-97
- [6] Lee SF(2012)Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors Am J Gastroenterol 107 569-577
- [7] Cheung YS(2009)Percutaneous radiofrequency ablation of hepatocellular carcinoma abutting the diaphragm and gastrointestinal tracts with the use of artificial ascites: safety and technical efficacy in 143 patients Eur Radiol 19 2630-2640
- [8] Chong CN(2003)Percutaneous ultrasound-guided radiofrequency ablation with artificial pleural effusion for hepatocellular carcinoma in the hepatic dome J Gastroenterol 38 1066-1070
- [9] Kim YS(2013)Fusion imaging-guided radiofrequency ablation for hepatocellular carcinomas not visible on conventional ultrasound Am J Roentgenol 201 1141-1147
- [10] Lim HK(2017)Real-time US-CT/MR fusion imaging for percutaneous radiofrequency ablation of hepatocellular carcinoma J Hepatol 66 347-354